Ninex at a glance
Ninex was founded in 2019 by Lars Kvarnhem and Bengt Julander, two seasoned investors with extensive experience in the Life Science sector. Having invested together through their own investment firms for many years, they decided to launch Ninex, driven by a shared passion for active ownership. Their goal was to contribute not only financially but also operationally, leveraging their deep industry knowledge and networks.
What sets Ninex apart from many other investment companies is this unique combination of capital and specialized MedTech expertise, creating optimal conditions for building sustainable and profitable businesses.
Ninex specializes in investing in small to medium-sized MedTech companies. We take a long-term approach by partnering closely with businesses, providing capital, strategic support, and access to our extensive network. Our decentralized model ensures that each portfolio company retains operational autonomy while benefiting from our tailored guidance.
With a management team experienced in supporting successful MedTech companies such as Stille, Linc, and Medcap, we are committed to creating lasting value in the healthcare sector.
Investment Strategy
We invest in established small to medium-sized MedTech companies led by entrepreneurial and dedicated management teams with a proven track record of growth and profitability. We seek businesses with scalable operations, high-quality products, and strong market positions, ready for their next phase of development.
Our focus is on companies where we can add value beyond capital by providing strategic guidance, operational support, and access to our global network. By combining entrepreneurial drive with our industry expertise and long-term perspective, we create the right conditions for sustainable growth, profitability, and lasting business success.
